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Summary 
When mice are lethally irradiated  and reconstituted with  allogeneic bone marrow cells,  their 
skin is repopulated over a period of several months with Langerhans cells (LC) of marrow donor 
origin.  Skin from such mice, when transplanted  to unirradiated  syngeneic recipients,  became 
in many cases the sites of intense inflammatory responses that led to varying degrees of destruction 
of the transplanted  skin and in some instances,  to rejection of the entire graft.  The frequency 
and intensity of these responses were influenced by the nature of the immunogenetic disparity 
between the donors and recipients of the marrow cells.  Chimeric  skin placed on hybrid mice 
derived from crosses between the marrow donors and recipients behaved in all respects as syngeneic 
grafts or autografts. When the recipients of the chimeric skin were presensitized to the antigens 
of the marrow donor, the responses were especially intense, and resulted in all cases in complete 
rejection.  Thus the immunologically mediated attack on the allogeneic LCs was accompanied 
by widespread and nonspecific destruction of bystander cells. In all cases, the inflammation  and 
tissue damage were confined sharply to the grafted skin,  showing clearly that  nonspecific or 
indirect tissue destruction is entirely consistent with highly selective destruction of grafted tissues. 
This finding removes a major objection to r~c~tulated mechanisms of rejection that involve indirect 
destruction  of grafted tissues. 
A  remarkable and consistent feature of the rejection of 
allografts is the absence of significant damage to host 
tissues that are close to or even in contact with elements of 
the grafts. In the case of skin, for example, microscopic ex- 
amination of fixed sections of a rejecting graft reveals an in- 
tense inflammatory response that is confined almost exclu- 
sively to the graft and its adjacent bed, and cell damage is 
found to stop abruptly at the plane that separates  graft and 
host tissues.  Moreover, even gross inspection of the rejecting 
graft conveys a sense  of strict selectivity. Similar or analo- 
gous observations have been made for grafts of other tissues 
and organs, and for transplanted tumors as well. This selec- 
tivity has long been recognized,  and attempts  to delineate 
mechanisms  of graft  rejection have had to take it into  ac- 
count.  It  is  not  surprising,  therefore,  that  the  striking 
specificity of killing exhibited by some T  cells in vitro has 
led to the widely held view that this activity reflects the role 
of these cells in the rejection of grafts in vivo (1). In partic- 
ular,  the absence of detectable effects on bystander cells in 
vitro has fostered the notion that cells of the graft are like- 
wise killed individually by cytotoxic T  cells. This is an at- 
tractive view insofar as it  accounts nicely for the selective 
destruction of donor cells, but it is not in accord with some 
important  features of rejection.  We have reported,  for ex- 
ample, that skin grafts undergoing acute rejection may con- 
tain  only  small  numbers  of T  cells  among  the  invading 
mononuclear cells, and the distribution of these T cells bears 
no obvious relationship  to the pattern of damage observed 
in the grafts (2). The paucity of T cells is particularly striking 
in the case of donor-recipient combinations that involve MHC 
class I disparity only, but destruction of donor cells is found 
to occur in the absence of contact with host T cells even when 
there is disparity with respect to all of the MHC antigens. 
This may, of course, reflect ischemic death occurring secon- 
darily to specific killing of endothelial cells, and indeed, we 
and others (3-6) have stressed the importance of the vascular 
bed as the major interface between the graft  and its host, 
and as a crucial target for cellular as well as humoral medi- 
ators of rejection.  Thus,  it is possible that  there is specific 
destruction of endothelial cells and that the selective destruc- 
tion of graft elements reflects the anatomic distribution  of 
donor vessels. Still,  the strict selectivity of destruction is ob- 
served even in the case of grafts of pure epidermis,  or full 
thickness grafts that are known to contain few, if any, donor 
endothelial cells, suggesting the possibility of an indirect at- 
tack on the vascular bed of the graft. Moreover, it has been 
observed that there are alterations in the vessels of host origin 
found in the graft bed that are indistinguishable from those 
seen in the vessels of grafts undergoing active rejection (3), 
and similar vascular responses are observed in delayed type 
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only as  indirect  consequences  of immune  reactions  (7). 
We have sought evidence in favor of indirect mechanisms 
of damage through the use of an experimental system in which 
skin from bone marrow chimeric mice was transplanted  to 
mice syngeneic to the marrow recipients.  These grafts  are 
immunogenetically compatible with  their hosts  except for 
bone marrow-derived cells, principally, if not solely, Langer- 
hans cells (LC). We report here that the immune responses 
engendered by these allogeneic cells lead to the induction of 
intense inflammatory responses that are strictly confined to, 
and frequently result in widespread  or total destruction of 
the grafts.  Thus,  destruction  of bystander cells is observed 
in a manner  that  is entirely consistent  with  the selectivity 
of graft  rejection. 
Materials  and  Methods 
Animals.  C3H/fSed mice were obtained from the Edwin L. 
Steele Laboratory of Radiation Biology, the Department of Radia- 
tion Oncology, Massachusetts  General Hospital, and all F1 mice 
of which they were parents were raised in our laboratories. All other 
mice were purchased from The Jackson Laboratory (Bar Harbor, 
ME).  CD rats were purchased from the Charles River Breeding 
Laboratories (Wilmington,  MA). 
Preparation of Bone Marrow Chimeric Mice.  C3H/fSed mice re- 
ceived  900-950  tad  total  body  irradiation  from  137Cs sources 
(Gamma Cell 40, AECL Technologies Inc., Rockville, MD) at a 
rate of 80 rad/min,  or (Mark I; JL Shepherd and Associates,  San 
Francisco,  CA) at 290 rad/min.  20 h  after irradiation,  the mice 
were given  15-20  x  106 allogeneic  bone marrow cells intrave- 
nously. They were housed in microisolator cages under sterile con- 
ditions for 14 d during which time they received tetracycline  in 
i  Abbreviations used in this  paper: DTH, delayed  type hypersensitivity;  LC, 
Langerhans cell 
their drinking water. Thereafter they were kept in microisolator 
cages under conventional conditions with acidified drinking water. 
Skin Grafts.  Mouse trunk skin was  transplanted as described 
(8) using 1.5 cm  2 full thickness grafts applied to the dorsolateral 
thoracic wall. The dressings  were removed 7 d after transplanta- 
tion and the grafts were inspected daily for signs of inflammation 
(erythema and edema) and necrosis. Rat ear skin was prepared and 
grafted to the dorsolateral thoracic wall of recipient mice as de- 
scribed  (9).  Briefly, the intended recipients were thymectomized 
2-3 wk before receiving the skin grafts. Their immune responses 
were further suppressed by the administration of  rabbit anti-mouse 
lymphocyte serum in doses of 0.25 ml 2 d before grafting, on the 
day of grafting, and on the second and fourth days after placement 
of the grafts. 
Results 
We have described in detail our observations on the acute 
destruction, by humoral antibody, of rat skin that had been 
transplanted to immunosuppressed mice (5, 6). It was clear 
from these studies  that  the reaction of antibodies with an- 
tigens on endothelial cells was sufficient to lead to the selec- 
tive destruction  of the  entire  graft.  In the course of these 
studies we found that grafts that had been in place for long 
periods of time on the suppressed mice lost their sensitivity 
to humoral antibodies, and this loss was associated with the 
replacement of donor (rat) endothelium by cells derived from 
the recipient mice. Thus, the rat endothelial cells seemed to 
be the principal,  and perhaps  sole target of the antibodies. 
Moreover, when these longstanding  grafts of rat skin were 
removed and regrafted onto rats  of the donor  strain,  they 
were without exception rejected acutely, whereas rat skin that 
had been  in  place  on mice for only 2-4  wk  was  accepted 
indefinitely when returned to the rat donors. The rejection 
of the long-term grafts was attributed to a ceU-mediated at- 
tack on the mouse endothelial cells. An example of this selec- 
Figure  1.  Rat  skin was  trans- 
planted to immunosuppressed mice, 
and at various  intervals  them'after  the 
grafts were removed with  a sur- 
rounding cuff of recipient mouse 
skin and returned to the original 
donor rats. (A) Graft retransplanted 
to original donor after a 92-d resi- 
dence on a suppressed  mouse. Both 
rat and mouse skin are completely 
rejected (9 d after regrafting). (B) 
Rat skin  returned  to donor after  14 d 
residence  on mouse. Note rejection 
of surrounding cuff of mouse skin 
in the absence  of  damage to the cen- 
tral  patch of rat  skin (9  d  after 
regrafting). 
1646  Destruction of Skin Grafts by Indirect Mechanisms Table  1.  Fate  of Skin  Taken from Bone Marrow Chimeras and Transplanted to Mice of the Marrow Donor and Recipient Strains 
Chimeric  donor  Recipient  Disparity  Inflammation  Partial 
Rejection 
Complete 
C3H.SW -" C3H 
C3H.SW  K IA IE D  5/5  - 
C3H  K IA-D*  5/5  3/5 
(C3H x C3H.SW)FI  None  0/5  - 
5/5 
2/5 
m 
* Disparity with respect to donor LC only. 
tive, though nonspecific, form of rejection is shown in Fig. 
1 A. In this case, we used rat ear skin so that we could return 
the grafts to the actual donors, avoiding, thereby, problems 
associated with genetic segregation within the strain of rats. 
Thus, the animal depicted here has,  like all of 11 others so 
treated, acutely rejected his  own ear skin in the course of 
attacking the mouse endothelial cells.  In removing the rat 
skin grafts from the mice we included small surrounding cuffs 
of the host skin that were grafted along with the rat skin. 
When 2-4-wk-old grafts were returned to the donors, there 
was complete destruction of the cuff of mouse skin with no 
detectable damage to the rat skin, an observation that under- 
scores the selectivity of the rejection process (Fig. 1 B). When 
longstanding grafts were transferred to mice syngeneic to the 
primary recipients, the surrounding cuffs of mouse skin were 
maintained in perfect condition whereas the rat skin was selec- 
tively rejected. The endothelium of these grafts was derived 
entirely, or almost entirely, from mouse cells. Thus, selective 
damage in this case might be attributed to an indirect attack 
on the vessels of the graft. To look for evidence of such in- 
direct effects,  we carried out the following experiments in 
which chimeric skin was grafted to syngeneic recipients who 
could respond only to the aUogeneic dendritic cells of the grafts. 
The Fate of C3H.SW -* C3H Chimeric Skin Grafted onto 
C3HRe@ients.  When mice are lethally irradiated and recon- 
stituted with allogeneic bone marrow, their skin is repopu- 
lated over a period of several months with LC of marrow 
donor origin (10). LC are important contributors to effector 
responses in skin, and they are also known to serve as stimu- 
lators of intense immune responses when placed in allogeneic 
recipients. We wished to determine whether they could serve 
as prime targets in the rejection of skin as well as initiators 
of the response to the presence of allogeneic tissue.  Accord- 
ingly, we lethally irradiated C3H mice and reconstituted them 
with C3H.SW bone marrow. 4 mo later, these mice were 
used as donors of skin grafts for C3H, C3H.SW, and (C3H 
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Figure 2.  C3H  -'*  C3H  skin 
was taken at 4 mo after  irradiation 
and reconstitution  with C3H.SW 
bone marrow, and grafted onto a 
C3H mouse.  Picture  taken  12 d after 
grafting shows selective  inflamma- 
tion of the graft. Subsequent fate 
of the graft is shown in Fig. 3 C. Figure 3.  C3H.SW -*  C3H 
chimeric skin was taken at 4 mo 
after irradiation and reconstitution 
with  C3H.SW  bone marrow. 
and  grafted onto (.4) (C3H  x 
C3H.SW)F1 mice. (B) C3H mice. 
Pictures  were  taken  30 d after  trans- 
plantation. (,4) Grafts on F1 mice 
are ftdly  intact and are indistinguish- 
able from syngeneic  grafts. (B and 
C) Responses  of C3H mice to chi- 
meric skin. (B) Complete  rejection 
with scarring; (C) partial rejection 
with about 15% of  donor skin sur- 
viving. 
x  C3H.SW)F, recipients.  The results of this experiment are 
summarized  in Table 1, and Figs.  2 and 3. As expected, all 
of five C3H.SW mice promptly rejected their grafts, and five 
of 5F1 mice retained the chimeric skin without  signs of re- 
jection. All of the grafts placed on C3H mice were severely 
inflamed within 24 h of removing the dressings, the inflam- 
mation showing the selectivity characteristic of rejection (Fig. 
2). Two of the grafts were rejected acutely. The other three 
were extensively damaged,  though  small portions of them 
survived and became normal in appearance after the inflam- 
matory process had subsided. (Fig. 3). The survival of a small 
amount of donor skin could be detected on the basis of the 
direction of hair growth.  The grafts were positioned in the 
beds such that  the hair would grow in a direction opposite 
to that  of recipient hair,  and the loss of pigment  in donor 
skin was due to radiation  damage.  Evidently,  some of the 
C3H.SW LC induced an allogeneic response in the draining 
lymph nodes, and the T  cells generated in the response en- 
tered the graft and reacted with the remaining C3H.SW cells, 
resulting in the induction of intense inflammatory responses 
that lead to tissue damage. The destruction of the C3H.SW 
LC removed the inciting antigen, and the inflammation abated 
allowing those C3H cells that escaped destruction to persist 
indefinitely.  It is important  to note  that  the  grafts  on the 
(C3H  x  C3H.SW)F1 behaved essentially as syngeneic grafts 
with only very mild and transient  signs of inflammation  at 
the time of removal of the dressings. Furthermore,  the inten- 
sity of the responses in the grafts on the C3H mice was at 
least as great during the first 2 d after removal of the dressings 
as those observed in the grafts on the C3H.SW recipients. 
Evidently,  allogeneic LC not only induced a rapid response 
but also played an important role in the rejection of the grafts. 
The Fate of  Chimeric Grafts in other  Donor-Recipient Combi- 
nations.  We have repeated this experiment using donor-re- 
cipient combinations that involve various kinds of immuno- 
genetic disparity,  as indicated in Table 2. The intensity and 
frequency of the inflammatory  responses that  we observed 
in the grafts varied among the different groups of"syngeneic" 
recipients,  but it is clear from the overall  results of the ex- 
periment  that  the phenomenon of selective but nonspecific 
damage of graft elements is a common event in the case of 
skin.  The numbers of animals  in individual  groups are too 
small to reach any firm conclusion with respect to the rela- 
tionships between the intensity of the responses and the na- 
ture of the immunogenetic diversity between the allogeneic 
dendritic cells and their recipients. However, it is interesting 
to note that  the most intense and destructive responses oc- 
curred in the B10.BK/C3H combination which involves mul- 
tiple minor histoincompatibilities  only, an observation that 
may  be  related  to  reports  that  DTH  reactions  to  minor 
histocompatibility antigens are particularly strong (11). Also, 
in the case where there was only an H-2D region difference 
(D  ~ ~  D a)  that  induces rejection responses of modest in- 
tensity, inflammation  occurred in only one of seven grafts. 
This and an observation made in a different context that chi- 
meric grafts involving I-A differences only were not rejected 
(12),  suggest  that  the destruction  of bystander cells occurs 
when the immune response to the dendritic cell antigens is 
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Rejection 
Chimeric donor  Recipient  Disparity  Inflammation  Partial  Complete 
B10.BR ~  C3H 
B6AF1 "~ B10.BR 
(C3H x C3H.SW)F1 "~ C3H 
B10.BR  Minor HA  5/5  -  5/5 
C3H  Minor HA*  4/4  3/4  1/4 
(B10.BR x C3H)F1  None  0/5  -  - 
B6AF1  ---D  30/30  -  30/30 
B10.BR  K I^-D*  19/27  8/27  5/27 
C3H  K IA-D*  7/7  2/7  2/7 
(C3H x B10.A[5R])F~  ---D*  1/7  1/7  - 
(C3H x C3H.SW)F1  None  0/7  -  - 
* Disparity with respect to donor LC only. 
HA, histocompatibility  antigen. 
acute and intense, circumstances that permit the destructive 
process to override repair and regeneration. In this connec- 
tion it is important to consider that cells containing the irri- 
tant represent a limiting factor that is consumed during the 
response.  Thus, in the case of a slowly evolving response, 
the intensity of inflammation may produce little damage to 
bystander cells and the effects on the vascular bed may be 
completely reversible. 
Fate of Chimeric Grafts Placed on Previously Sensitized Recip- 
ients.  The mechanisms of nonspecific but selective destruc- 
tion of aUografts that we propose here suggest that presen- 
sitization of intended recipients with tissue from the mouse 
strain that served as donor of the bone marrow would lead 
to more vigorous and extensive  damage to chimeric grafts 
than is observed in nonprimed mice. Accordingly, we trans- 
planted B6AF1 skin to B10.D2 mice and 2-3 wk after the 
grafts had been rejected,  we placed B6AF1 ~  B10.D2 chi- 
meric skin on these rejectors  which had become sensitized 
to B6AF1 aUoantigens.  The results of this experiment are 
presented in Table 3. As expected, the chimeric skin was re- 
jected acutely by all of the B6AF1 recipients.  All four chi- 
meric grafts placed  on nonsensitized B10.D2 mice became 
moderately to intensely inflamed 2-7 d after removal of the 
graft dressings.  One of these grafts was completely rejected 
by day 16,  two of them were partially destroyed, and the 
remaining graft recovered completely. In the case of the sen- 
sitized recipients, all four grafts were completely rejected, two 
by day 10, and two by days 15 and 16. Thus, these results 
affirm in a dramatic way the occurrence of selective and com- 
plete destruction of skin grafts through the interaction of 
host lymphocytes with a relatively small number of nonvas- 
cular targets. 
Discussion 
The prime role of  APCs in the induction of states of trans- 
plantation immunity, initially enunciated in terms of the pas- 
senger leukocyte hypothesis (13), has been recognized for sev- 
eral decades, but the possibility that these cells may serve as 
important targets in the rejection of allografts seems not to 
have been seriously considered. This oversight is surprising 
in view of the well-known involvement of dendritic cells in 
Table  3.  Fate  of Skin  Taken from B6AFI  ~  BIO.D2 Bone Marrow Chimeras and Transplanted to Mice of the Recipient Strain 
That Had Previously Rejected B6AFI Skin 
Chimeric donor  Recipient  Disparity  Inflammation  Partial 
Rejection 
Complete 
B6AF1 "~ B10.D2 
B6AF1  K IA I~-  4/4  - 
B10.D2  K IA IE D*  4/4  1/4 
B10.D2*  K IA IE D*  4/4  - 
4/4 
1/4 
4/4 
* Disparity with respect to donor LC only. 
Rejected normal B6AF1 skin 1 mo previously. 
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pect that the dendritic cells in skin, for example, would present 
their resident alloantigens to effector cells just as they do with 
environmental antigens.  Indeed, in view of our understanding 
of the function of MHC molecules it seems inevitable that 
DTH reactions would be found to be involved in the rejec- 
tion of allografts. Thus our observations, which can be ex- 
plained only on the basis of the interaction of sensitized cells 
of the host with dendritic cells in the grafts, might well have 
been anticipated, and what is surprising is that they have not 
been reported much earlier.  The reasons that this potentially 
important pathway of responsiveness has gone almost unno- 
ticed have both conceptual and experimental origins.  As men- 
tioned above, the striking selectivity of graft rejection seemed 
intuitively incompatible with DTH reactions as an explana- 
tion for graft rejection, and the discovery of CTL with their 
specificity for target cells provided a more satisfying albeit 
unproven explanation  for the phenomenon.  The data  that 
we report here, however, make it abundantly clear that the 
selectivity of tissue destruction that is seen in grafts under- 
going rejection need not entail the killing of cells individu- 
ally by effector substances,  and  need  not  remove indirect 
effector mechanisms from consideration of the pathways of 
rejection. 
Nevertheless, there are experimental data that  have been 
offered as strong evidence against the involvement of indirect 
mechanisms.  These data come from  studies in which  skin 
from tetraparental  mice was grafted onto recipients that shared 
the MHC antigens of one set of parents but were incompat- 
ible with those of the other parents. Thus, these grafts con- 
sisted of a complex mosaic of histocompatible and histoin- 
compatible cells, and induced responses that resulted in the 
destruction of variable proportions of the transplanted tissue. 
Because the surviving tissue contained only histocompatible 
cells, it was concluded in the report of the initial study (14) 
that there had been selective destruction of the incompatible 
cells. However, that conclusion cannot be sustained because 
it is virtually impossible to determine the genotypes of all 
of the individual cells that comprise the grafts.  Whereas it 
can be determined that all of the incompatible cells have been 
destroyed and that  only compatible ones remain,  it cannot 
be known whether or not significant numbers of compatible 
cells were rejected.  Indeed,  in a subsequent  study,  Rosen- 
berg and Singer  (15) found that  there was substantial loss 
of compatible as well as incompatible cells.  However, they 
concluded that the inflammation that led to nonspecific de- 
struction of epidermal cells did not cause rejection of the grafts, 
and that "rejection of skin aUografts is mediated by antigen 
specific effector T cells that assess individual cells within the 
dermis of the graft for expression of foreign histocompati- 
bility antigens" 
We come to a very different conclusion on the basis of 
our results but we find no difficulty in resolving the differ- 
ence.  The  skin that  we used for grafting  came from mice 
that had received lethal doses of ionizing radiation and res- 
cuing doses of aUogeneic bone marrow  cells  4  mo before 
serving as donors.  There was time,  then,  for all or nearly 
all of the LC that were present in skin at the time of irradia- 
tion to have been replaced by cells from the donor marrow, 
thereby insuring an ample supply to serve as allogeneic stimu- 
lators and targets of effector cells when grafted to mice other- 
wise syngeneic with the donor. The skin of tetraparental  mice, 
on the other hand, consists of cells of two distinct genotypes, 
the relative numbers of which vary from time to time and 
place to place in individual  mice. Accordingly,  the density 
of LC that  are foreign to recipients of either parental  type 
is variable and very likely to be lower than is the case in our 
experimental  system.  Furthermore,  in  the  experiments  of 
Rosenberg and Singer  (15) the grafts were in place on B6 
nude mice for 31 d before the animals received spleen cells 
from euthymic B6 donors. That period of time would have 
resulted in replacement of some allogeneic LC by syngeneic 
ones, resulting in further reductions of immunogenicity and 
responsiveness to effector cells. Like Rosenberg and Singer, 
we have found that portions of grafts that become intensely 
inflamed frequently recover, and occasionally there is recovery 
of all or nearly all of the grafted tissue. However, when the 
responses to the grafts were sufficiently intense, as in the case 
where the recipients had been sensitized to the alloantigens 
of the LC in the chimeric skin,  all of the grafts were com- 
pletely rejected,  and whenever there was strong immuno- 
genetic disparity between the LC and the recipient,  a significant 
proportion of first set grafts was completely rejected.  We con- 
clude that the interaction between LC and T cells specifically 
sensitized to the alloantigens of the LC can lead to a highly 
selective and complete rejection of skin grafts. Thus, we do 
not see our results as conflicting with those found in studies 
using tetraparental mice as donors. Rather, we feel that our 
experimental system involves inflammatory responses that are 
more  intense  and  more  pervasive  than  is  the  case  for 
tetraparental grafts,  and that such intense responses can cause 
complete and selective  destruction of skin grafts in the ab- 
sence of specific attacks on cells other than LC. The selec- 
tivity is due, in our view, to the anatomic arrangement  of 
the microvasculature of the graft. These small vessels, which 
are especially responsive to vasoactive and thrombogenic factors 
released  by the interaction  of T  cells and LC, are so placed 
as to have ready access to such substances, and their pattern 
of distribution is such that they nourish only cells of the graft. 
Thus, we see selectivity of destruction in these experimental 
systems as a reflection of irreversible damage to the microvas- 
cular bed. 
There are also two reports  (12,  16) in which skin from 
chimeric mice was transplanted  to mice syngeneic with the 
bone marrow  recipients using experimental  systems much 
like those that  we have employed in our study.  In neither 
report was the rejection of such grafts recorded.  However, 
in one case the skin was taken from the chimeras shortly after 
they had been reconstituted with  allogeneic bone marrow 
cells,  and as the author has pointed out, it is unlikely that 
this skin contained more than a small number of allogeneic 
LC (16). In the other case, the marrow donors an d recipients 
differed only with respect to an I-A antigen that induced only 
a moderate rejection response (12). It is not surprising or in- 
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port observed transient crises in some grafts but no overt de- 
struction of the grafted tissue. The results of both studies 
are in keeping with our suggestion that slowly evolving re- 
sponses to chimeric grafts may remove the source of antigen 
without  causing irreversible damage  to the grafts. 
Our results do not, of course, exclude mechanisms of re- 
jection involving specific killing of targets in the absence of 
bystander effects.  Indeed,  the studies carried out with  the 
tetraparental animals provide strong evidence for such a mech- 
anism. Moreover, rejection in some circumstances may be trace- 
able largely or exclusively to specific  mechanisms.  For ex- 
ample, when mixtures containing small numbers of syngeneic 
tumor cells and very much larger numbers of allogeneic tumor 
cells are implanted into mice, the latter grow into easily mea- 
surable tumors which regress, and the former develop at the 
site of rejection into progressively growing tumors with no 
evidence that the times of appearance or rates of growth of 
these syngeneic cells have been affected by the rejection of 
the allogeneic cells (17). These observations point to a highly 
specific attack on individual target cells. The additional ob- 
servation that the rejection of allogeneic tumors can be com- 
pletely abrogated by depleting host CD8 cells alone (18), sup- 
ports the view that the tumor cells in these cases are destroyed 
individually by CTL. It may be significant that there are no 
donor dendritic cells to serve as stimulators or targets in these 
tumor grafts.  The importance of selective,  but nonspecific 
forms of damage in the rejection of other types of grafts re- 
mains  to be determined. 
Finally, it is important to consider the relationship between 
the process of rejection that we describe here and a related 
process that has been considered from time to time over the 
past four decades viz destruction of grafted tissues by DTH 
reactions.  In this process it is suggested that graft alloantigens 
are processed, and peptides derived thereby are presented by 
recipient APC so as to activate CD4 + T  cells which enter 
the graft and incite DTH reactions by interacting with host 
APC presenting donor antigens. Implicit in this formulation 
is the suggestion that rejection involves damage to bystander 
cells. This hypothesis has always had some merit and the pre- 
sentation of donor-derived peptides by host APC, implicit 
in the widespread observation of humoral antibody responses 
to MHC antigens, has recently received direct support from 
studies carried out in several laboratories (19, 20). However, 
it has not been possible to obtain direct evidence for nonspecific 
mechanisms  of rejection,  and the high selectivity of tissue 
destruction observed during the rejection process has been 
widely viewed as being inconsistent with damage caused to 
bystander cells. The data presented here do not deal directly 
with the DTH hypothesis insofar as our experimental system 
seems to involve direct recognition of alloantigens on donor 
cells during both the inductor and effector stages of the im- 
mune response. Nevertheless, they do make it clear that re- 
jection of grafts by mechanisms that destroy bystander cells 
in an antigen nonspecific manner does occur and is entirely 
consistent with the selective destruction of allografts.  Accord- 
ingly, they not only provide direct and convincing evidence 
for the path of tissue destruction  described here, but they 
also remove a major objection to other postulated mecha- 
nisms of rejection that involve indirect destruction of grafts. 
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